Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Tomas Bos

    TitlePostdoctoral Scholar
    SchoolUniversity of California, San Diego
    DepartmentCellular and Molecular Medicine
    Address9500 Gilman Drive #0695
    CA La Jolla 92093
    Phone858-729-3649
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Huggins IJ, Bos T, Gaylord O, Jessen C, Lonquich B, Puranen A, Richter J, Rossdam C, Brafman D, Gaasterland T, Willert K. The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells. Nat Commun. 2017 Oct 18; 8(1):1034. PMID: 29044119.
        View in: PubMed
      2. Batra R, Stark TJ, Clark E, Belzile JP, Wheeler EC, Yee BA, Huang H, Gelboin-Burkhart C, Huelga SC, Aigner S, Roberts BT, Bos T, Sathe S, Donohue JP, Rigo F, Ares M, Spector DH, Yeo GW. RNA-binding protein CPEB1 remodels host and viral RNA landscapes. Nat Struct Mol Biol. 2016 Dec; 23(12):1101-1110. PMID: 27775709.
        View in: PubMed
      3. Bos T, Nussbacher JK, Aigner S, Yeo GW. Tethered Function Assays as Tools to Elucidate the Molecular Roles of RNA-Binding Proteins. Adv Exp Med Biol. 2016; 907:61-88. PMID: 27256382.
        View in: PubMed
      4. Goethals LR, Bos T, Baeyens L, De Geeter F, Devoogdt N, Lahoutte T. Camelid reporter gene imaging: a generic method for in vivo cell tracking. EJNMMI Res. 2014; 4:32. PMID: 25024930; PMCID: PMC4086443.
      5. Emeagi PU, Van Lint S, Goyvaerts C, Maenhout S, Cauwels A, McNeish IA, Bos T, Heirman C, Thielemans K, Aerts JL, Breckpot K. Proinflammatory characteristics of SMAC/DIABLO-induced cell death in antitumor therapy. Cancer Res. 2012 Mar 15; 72(6):1342-52. PMID: 22379024.
        View in: PubMed
      6. Keyaerts M, Remory I, Caveliers V, Breckpot K, Bos T, Poelaert J, Bossuyt A, Lahoutte T. Inhibition of firefly luciferase by general anesthetics: effect on in vitro and in vivo bioluminescence imaging. PLoS One. 2012; 7(1):e30061. PMID: 22253879; PMCID: PMC3254645.
      7. Dmitriev P, Petrov A, Ansseau E, Stankevicins L, Charron S, Kim E, Bos T, Robert T, Turki A, Coppée F, Belayew A, Lazar V, Carnac G, Laoudj D, Lipinski M, Vassetzky YS. The Krüppel-like factor 15 as a molecular link between myogenic factors and a chromosome 4q transcriptional enhancer implicated in facioscapulohumeral dystrophy. J Biol Chem. 2011 Dec 30; 286(52):44620-31. PMID: 21937448; PMCID: PMC3247939.
      8. Bos T, De Bruyne E, Van Lint S, Heirman C, Vanderkerken K. Large double copy vectors are functional but show a size-dependent decline in transduction efficiency. J Biotechnol. 2010 Oct 01; 150(1):37-40. PMID: 20638430.
        View in: PubMed
      9. De Bruyne E, Bos T, Schuit F, Van Valckenborgh E, Menu E, Thorrez L, Atadja P, Jernberg-Wiklund H, Vanderkerken K. IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanisms. Blood. 2010 Mar 25; 115(12):2430-40. PMID: 20086250.
        View in: PubMed
      10. Caers J, Hose D, Kuipers I, Bos T, Van Valckenborgh E, Menu E, De Bruyne E, Goldschmidt H, Van Camp B, Klein B, Vanderkerken K. Thymosin ß4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma. Haematologica. 2010 Jan; 95(1):163-7. PMID: 19833631; PMCID: PMC2805724.
      11. Bos T, De Bruyne E, Heirman C, Vanderkerken K. In search of the most suitable lentiviral shRNA system. Curr Gene Ther. 2009 Jun; 9(3):192-211. PMID: 19519364.
        View in: PubMed
      12. Baeyens L, Bonné S, Bos T, Rooman I, Peleman C, Lahoutte T, German M, Heimberg H, Bouwens L. Notch signaling as gatekeeper of rat acinar-to-beta-cell conversion in vitro. Gastroenterology. 2009 May; 136(5):1750-60.e13. PMID: 19208356.
        View in: PubMed
      13. De Bruyne E, Bos T, Asosingh K, Vande Broek I, Menu E, Van Valckenborgh E, Atadja P, Coiteux V, Leleu X, Thielemans K, Van Camp B, Vanderkerken K, Van Riet I. Epigenetic silencing of the tetraspanin CD9 during disease progression in multiple myeloma cells and correlation with survival. Clin Cancer Res. 2008 May 15; 14(10):2918-26. PMID: 18483358.
        View in: PubMed
      14. Bonehill A, Tuyaerts S, Van Nuffel AM, Heirman C, Bos T, Fostier K, Neyns B, Thielemans K. Enhancing the T-cell stimulatory capacity of human dendritic cells by co-electroporation with CD40L, CD70 and constitutively active TLR4 encoding mRNA. Mol Ther. 2008 Jun; 16(6):1170-80. PMID: 18431362.
        View in: PubMed
      15. Keyaerts M, Verschueren J, Bos T, Tchouate-Gainkam LO, Peleman C, Breckpot K, Vanhove C, Caveliers V, Bossuyt A, Lahoutte T. Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of D: -luciferin: effect on intensity, time kinetics and repeatability of photon emission. Eur J Nucl Med Mol Imaging. 2008 May; 35(5):999-1007. PMID: 18180921.
        View in: PubMed
      16. Smith LM, Wise SC, Hendricks DT, Sabichi AL, Bos T, Reddy P, Brown PH, Birrer MJ. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene. 1999 Oct 28; 18(44):6063-70. PMID: 10557095.
        View in: PubMed
      17. Bos T. Oncogenes and cell growth. Adv Exp Med Biol. 1992; 321:45-9; discussion 51. PMID: 1333167.
        View in: PubMed
      18. Vogt PK, Bos T. jun: oncogene and transcription factor. Adv Cancer Res. 1990; 55:1-35. PMID: 2166997.
        View in: PubMed
      19. Pertovaara L, Sistonen L, Bos T, Vogt PK, Keski-Oja J, Alitalo K. Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation. Mol Cell Biol. 1989 Mar; 9(3):1255-62. PMID: 2725496; PMCID: PMC362716.
      20. Bos T, Bohmann D, Tsuchie H, Tjian R, Vogt PK. v-jun encodes a nuclear protein with enhancer binding properties of AP-1. Cell. 1988 Mar 11; 52(5):705-12. PMID: 2830989.
        View in: PubMed
      21. Ball AR, Bos T, Löliger C, Nagata LP, Nishimura T, Su H, Tsuchie H, Vogt PK. Jun: oncogene and transcriptional regulator. Cold Spring Harb Symp Quant Biol. 1988; 53 Pt 2:687-93. PMID: 2855501.
        View in: PubMed
      22. Bohmann D, Bos T, Admon A, Nishimura T, Vogt PK, Tjian R. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science. 1987 Dec 04; 238(4832):1386-92. PMID: 2825349.
        View in: PubMed
      Tomas's Networks
      Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Similar People
      People who share similar concepts with this person.
      _
      Same Department
      Physical Neighbors
      People whose addresses are nearby this person.
      _